482 related articles for article (PubMed ID: 25583658)
21. Radiation therapy dose is associated with improved survival for unresected anaplastic thyroid carcinoma: Outcomes from the National Cancer Data Base.
Pezzi TA; Mohamed ASR; Sheu T; Blanchard P; Sandulache VC; Lai SY; Cabanillas ME; Williams MD; Pezzi CM; Lu C; Garden AS; Morrison WH; Rosenthal DI; Fuller CD; Gunn GB
Cancer; 2017 May; 123(9):1653-1661. PubMed ID: 28026871
[TBL] [Abstract][Full Text] [Related]
22. Role of surgery in the management of anaplastic thyroid carcinoma: Korean nationwide multicenter study of 329 patients with anaplastic thyroid carcinoma, 2000 to 2012.
Baek SK; Lee MC; Hah JH; Ahn SH; Son YI; Rho YS; Chung PS; Lee YS; Koo BS; Jung KY; Lee BJ
Head Neck; 2017 Jan; 39(1):133-139. PubMed ID: 27534388
[TBL] [Abstract][Full Text] [Related]
23. Anaplastic and poorly differentiated thyroid carcinoma: therapeutic strategies and treatment outcome of 52 consecutive patients.
Siironen P; Hagström J; Mäenpää HO; Louhimo J; Heikkilä A; Heiskanen I; Arola J; Haglund C
Oncology; 2010; 79(5-6):400-8. PubMed ID: 21455012
[TBL] [Abstract][Full Text] [Related]
24. Approach to the patient with anaplastic thyroid carcinoma.
Smallridge RC
J Clin Endocrinol Metab; 2012 Aug; 97(8):2566-72. PubMed ID: 22869844
[TBL] [Abstract][Full Text] [Related]
25. Spanish consensus for the management of patients with advanced radioactive iodine refractory differentiated thyroid cancer.
Riesco-Eizaguirre G; Galofré JC; Grande E; Zafón Llopis C; Ramón y Cajal Asensio T; Navarro González E; Jiménez-Fonseca P; Santamaría Sandi J; Gómez Sáez JM; Capdevila J
Endocrinol Nutr; 2016 Apr; 63(4):e17-24. PubMed ID: 26601805
[TBL] [Abstract][Full Text] [Related]
26. Diagnosis and Management of Anaplastic Thyroid Cancer.
Chintakuntlawar AV; Foote RL; Kasperbauer JL; Bible KC
Endocrinol Metab Clin North Am; 2019 Mar; 48(1):269-284. PubMed ID: 30717908
[TBL] [Abstract][Full Text] [Related]
27. Anaplastic thyroid carcinoma: behavior, biology, and therapeutic approaches.
Ain KB
Thyroid; 1998 Aug; 8(8):715-26. PubMed ID: 9737368
[TBL] [Abstract][Full Text] [Related]
28. CAR T Therapy Targeting ICAM-1 Eliminates Advanced Human Thyroid Tumors.
Min IM; Shevlin E; Vedvyas Y; Zaman M; Wyrwas B; Scognamiglio T; Moore MD; Wang W; Park S; Park S; Panjwani S; Gray KD; Tassler AB; Zarnegar R; Fahey TJ; Jin MM
Clin Cancer Res; 2017 Dec; 23(24):7569-7583. PubMed ID: 29025766
[No Abstract] [Full Text] [Related]
29. Poorly differentiated and anaplastic thyroid cancer.
Patel KN; Shaha AR
Cancer Control; 2006 Apr; 13(2):119-28. PubMed ID: 16735986
[TBL] [Abstract][Full Text] [Related]
30. Induction chemotherapy with weekly paclitaxel administration for anaplastic thyroid carcinoma.
Higashiyama T; Ito Y; Hirokawa M; Fukushima M; Uruno T; Miya A; Matsuzuka F; Miyauchi A
Thyroid; 2010 Jan; 20(1):7-14. PubMed ID: 20025538
[TBL] [Abstract][Full Text] [Related]
31. Association of Treatment Strategies and Tumor Characteristics With Overall Survival Among Patients With Anaplastic Thyroid Cancer: A Single-Institution 21-Year Experience.
Wu SS; Lamarre ED; Yalamanchali A; Brauer PR; Hong H; Reddy CA; Yilmaz E; Woody N; Ku JA; Prendes B; Burkey B; Nasr C; Skugor M; Heiden K; Chute DJ; Knauf JA; Campbell SR; Koyfman SA; Geiger JL; Scharpf J
JAMA Otolaryngol Head Neck Surg; 2023 Apr; 149(4):300-309. PubMed ID: 36757708
[TBL] [Abstract][Full Text] [Related]
32. Optimal combination of treatment modality to increase survival in patients with anaplastic thyroid carcinoma: A STROBE compliant retrospective study.
Lee JH; Ahn HK; Seok JY; Lee KC; Chun YS; Chung YS; Lee YD
Medicine (Baltimore); 2018 Jun; 97(25):e11037. PubMed ID: 29923991
[TBL] [Abstract][Full Text] [Related]
33. Prognostic factors and treatment outcomes of 100 cases of anaplastic thyroid carcinoma.
Akaishi J; Sugino K; Kitagawa W; Nagahama M; Kameyama K; Shimizu K; Ito K; Ito K
Thyroid; 2011 Nov; 21(11):1183-9. PubMed ID: 21936674
[TBL] [Abstract][Full Text] [Related]
34. Combination of Novel Therapies and New Attempts in Anaplastic Thyroid Cancer.
Li W; Li Y; Li J; Pang H
Technol Cancer Res Treat; 2023; 22():15330338231169870. PubMed ID: 37122242
[TBL] [Abstract][Full Text] [Related]
35. [Differential diagnosis and strategy for the treatment of anaplastic thyroid carcinoma].
Suzuki S
Nihon Rinsho; 2007 Nov; 65(11):2079-86. PubMed ID: 18018574
[TBL] [Abstract][Full Text] [Related]
36. Anaplastic thyroid carcinoma: review of treatment protocols.
Tiedje V; Stuschke M; Weber F; Dralle H; Moss L; Führer D
Endocr Relat Cancer; 2018 Mar; 25(3):R153-R161. PubMed ID: 29295821
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of anaplastic thyroid carcinoma in the Kurdistan region of Iraq.
Mustafa DH; Ahmed BS; Haweizy RM; Dewana AM
BMC Surg; 2022 Oct; 22(1):364. PubMed ID: 36271386
[TBL] [Abstract][Full Text] [Related]
38. [Personalized approach to anaplastic thyroid carcinoma].
Wächter S; Bartsch DK; Maurer E
Chirurgie (Heidelb); 2024 Mar; 95(3):192-199. PubMed ID: 37973622
[TBL] [Abstract][Full Text] [Related]
39. Anaplastic thyroid carcinoma: A comprehensive review of current and future therapeutic options.
Perri F; Lorenzo GD; Scarpati GD; Buonerba C
World J Clin Oncol; 2011 Mar; 2(3):150-7. PubMed ID: 21611089
[TBL] [Abstract][Full Text] [Related]
40. Management of the compromised airway and role of tracheotomy in anaplastic thyroid carcinoma.
Mani N; McNamara K; Lowe N; Loughran S; Yap BK
Head Neck; 2016 Jan; 38(1):85-8. PubMed ID: 25215461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
